Please provide your email address to receive an email when new articles are posted on . An AI algorithm produced consistent measurements of tumor-infiltrating lymphocytes in patients with melanoma.

With all the excitement over the new immune-checkpoint inhibitor drugs in melanoma, many of which are not yet available, it's easy to overlook another immunotherapy — tumor infiltrating lymphocytes ...

Tumor-infiltrating lymphocytes (TILs) are a grouping of mostly T cells that enter tumors and elicit an initial immune response. But as Jason Bock, PhD, co-founder and CEO of CTMC, explains, “These ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Alla Pinzour, a Hawthorne Woods resident, has had a ...

While the rates of metastatic melanoma are on the rise—particularly in younger people—TIL (tumor-infiltrating lymphocyte) therapy at Fox Chase Cancer Center is a high-risk, high-reward therapy for ...

OBX-115 is an engineered tumor-derived autologous T cell immunotherapy (tumor-infiltrating lymphocyte cell therapy) armed with membrane-bound interleukin-15. The Food and Drug Administration (FDA) has ...

Turnstone Biologics is narrowing the focus of phase 1 trials of its lead tumor-infiltrating lymphocyte (TIL) therapy, with cutaneous melanoma and breast cancer no longer in the mix. The program, ...

The cutting edge of treating solid tumors with cell therapies got notably sharper this year. As the director of Solid Tumor Cell Therapy and leader of Stanford Medicine’s Melanoma and Cutaneous ...

Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is ...

Toni English’s medical team was giddy. It was six weeks after English had completed an experimental cancer treatment, and she had arrived at the Orlando Health Cancer Institute in Florida with her ...

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with advanced melanoma cancer – the first time local patients have been treated with ...